329
Views
21
CrossRef citations to date
0
Altmetric
SORANFENIB ENHANCES RADIOSENSITIVITY IN LIVER CANCER CELLS

Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway

, , , , &
Pages 724-731 | Received 23 Jun 2012, Accepted 26 Mar 2013, Published online: 31 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jen-Yang Tang, Chih-Wen Shu, Chun-Lin Wang, Sheng-Chieh Wang, Meng-Yang Chang, Li-Ching Lin & Hsueh-Wei Chang. (2019) Sulfonyl chromen-4-ones (CHW09) shows an additive effect to inhibit cell growth of X-ray irradiated oral cancer cells, involving apoptosis and ROS generation. International Journal of Radiation Biology 95:9, pages 1226-1235.
Read now
John E. Moulder. (2019) Chemical radiosensitizers: the Journal history. International Journal of Radiation Biology 95:7, pages 940-944.
Read now
Ehsan Salari, Jan Unkelbach & Thomas Bortfeld. (2015) A mathematical programming approach to the fractionation problem in chemoradiotherapy. IIE Transactions on Healthcare Systems Engineering 5:2, pages 55-73.
Read now

Articles from other publishers (18)

Michel M. Ouellette, Sumin Zhou & Ying Yan. (2022) Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. Diagnostics 12:3, pages 656.
Crossref
Chao Wei, Ben Wang, Zhong-Huo Chen, Han Xiao, Lei Tang, Jia-Fu Guan, Rong-Fa Yuan, Xin Yu, Zhi-Gang Hu, Hua-Jun Wu, Zhi Dai & Kai Wang. (2022) Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods. Frontiers in Oncology 12.
Crossref
Henning Willers, Xiao Pan, Nathalie Borgeaud, Irina Korovina, Lydia Koi, Regina Egan, Patricia Greninger, Aliza Rosenkranz, Jong Kung, Andrew S. Liss, Leslie A. Parsels, Meredith A. Morgan, Theodore S. Lawrence, Steven H. Lin, Theodore S. Hong, Beow Y. Yeap, Lori J. Wirth, Aaron N. Hata, Christopher J. Ott, Cyril H. Benes, Michael Baumann & Mechthild Krause. (2021) Screening and Validation of Molecular Targeted Radiosensitizers. International Journal of Radiation Oncology*Biology*Physics 111:5, pages e63-e74.
Crossref
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez & Ángela Matías-Pérez. (2021) Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination. Cancers 13:2, pages 192.
Crossref
Chen-Hsi Hsieh, Yu-Jen Chen, Tung-Hu Tsai, Li-Ying Wang, Hung-Chi Tai, Hsiang-Ling Huang & Yu-Chuen Huang. (2020) Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters. Scientific Reports 10:1.
Crossref
Michel M. Ouellette & Ying Yan. (2019) Radiation‐activated prosurvival signaling pathways in cancer cells. Precision Radiation Oncology 3:3, pages 111-120.
Crossref
Jing Luo, Zhong-Zhou Si, Ting Li, Jie-Qun Li, Zhong-Qiang Zhang, Guang-Shun Chen, Hai-Zhi Qi & Hong-Liang Yao. (2019) MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway. American Journal of Physiology-Cell Physiology 316:3, pages C299-C311.
Crossref
Kaweh Beizaei, Lisa Gleißner, Konstantin Hoffer, Lara Bußmann, Anh Thu Vu, Leonhard Steinmeister, Simon Laban, Nikolaus Möckelmann, Adrian Münscher, Cordula Petersen, Kai Rothkamm & Malte Kriegs. (2018) Receptor tyrosine kinase MET as potential target of multi‐kinase inhibitor and radiosensitizer sorafenib in HNSCC. Head & Neck.
Crossref
Hamidreza Badri, Ehsan Salari, Yoichi Watanabe & Kevin Leder. (2018) Optimizing Chemoradiotherapy to Target Metastatic Disease and Tumor Growth. INFORMS Journal on Computing 30:2, pages 259-277.
Crossref
Ji-wei Ma, Yong Zhang, Ji-cheng Ye, Ru Li, Yu-Lin Wen, Jian-xian Huang & Xue-yun Zhong. (2017) Tetrandrine Exerts a Radiosensitization Effect on Human Glioma through Inhibiting Proliferation by Attenuating ERK Phosphorylation. Biomolecules & Therapeutics 25:2, pages 186-193.
Crossref
Matthias Riedel, Nina Struve, Justus Müller-Goebel, Sabrina Köcher, Cordula Petersen, Ekkehard Dikomey, Kai Rothkamm & Malte Kriegs. (2016) Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines. Oncotarget 7:38, pages 61988-61995.
Crossref
Kuo-Hsin Chen, Meng-Tzu Weng, Yueh-Hung Chou, Yueh-Feng Lu & Chen-Hsi Hsieh. (2016) Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma. Medicine 95:11, pages e3133.
Crossref
WEI-LU WU, WEI-YA WANG, WEN-QING YAO & GAN-DI LI. (2015) Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. International Journal of Molecular Medicine 36:6, pages 1713-1719.
Crossref
Sunil J. Advani, Maria Fernanda Camargo, Laetitia Seguin, Ainhoa Mielgo, Sudarshan Anand, Angel M. Hicks, Joseph Aguilera, Aleksandra Franovic, Sara M. Weis & David A. Cheresh. (2015) Kinase-independent role for CRAF-driving tumour radioresistance via CHK2. Nature Communications 6:1.
Crossref
Qi Liu, Meng Wang, Ashley M. Kern, Saman Khaled, Jing Han, Beow Y. Yeap, Theodore S. Hong, Jeff Settleman, Cyril H. Benes, Kathryn D. Held, Jason A. Efstathiou & Henning Willers. (2015) Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers. Molecular Cancer Research 13:4, pages 713-720.
Crossref
Jennifer W. Harris, Tianyan Gao & B. Mark Evers. 2015. Intestinal Tumorigenesis. Intestinal Tumorigenesis 101 135 .
ASHLEY L. HEIN, MICHEL M. OUELLETTE & YING YAN. (2014) Radiation-induced signaling pathways that promote cancer cell survival (Review). International Journal of Oncology 45:5, pages 1813-1819.
Crossref
E. Gabriela Chiorean, Bryan P. Schneider, Fatih M. Akisik, Susan M. Perkins, Stephen Anderson, Cynthia S. Johnson, John DeWitt, Paul Helft, Romnee Clark, Erica L. Johnston, A. John Spittler, Jill Deluca, Guixue Bu, Safi Shahda, Patrick J. Loehrer, Kumar Sandrasegaran & Higinia R. Cardenes. (2014) Phase 1 Pharmacogenetic and Pharmacodynamic Study of Sorafenib With Concurrent Radiation Therapy and Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 89:2, pages 284-291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.